137 related articles for article (PubMed ID: 16422249)
1. Effect of losartan on slowing progression of chronic allograft nephropathy.
Wang PX; Fan MQ; Huang CB; Feng JY; Xiao Y; Fang ZQ; Zhang YP
Chin Med Sci J; 2005 Dec; 20(4):231-6. PubMed ID: 16422249
[TBL] [Abstract][Full Text] [Related]
2. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F
Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy.
Mas VR; Alvarellos T; Maluf DG; Ferreira-Gonzalez A; Oliveros L; Maldonado RA; de Boccardo G
Transpl Int; 2004 Oct; 17(9):540-4. PubMed ID: 15349718
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
Gunduz Z; Dursun N; Akgun H; Ozturk F; Okur H; Koc N
Regul Pept; 2005 Dec; 132(1-3):59-66. PubMed ID: 16229907
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients.
el-Agroudy AE; Hassan NA; Foda MA; Ismail AM; el-Sawy EA; Mousa O; Ghoneim MA
Am J Nephrol; 2003; 23(5):300-6. PubMed ID: 12904684
[TBL] [Abstract][Full Text] [Related]
6. [Association between TGF-Beta1 in allograft and chronic allograft nephropathy].
Wang PX; Fan MQ; Gong GZ; Xu HY; Huang CB; Zhang GT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):112-4, 122. PubMed ID: 16468656
[TBL] [Abstract][Full Text] [Related]
7. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy.
Campistol JM; Iñigo P; Larios S; Bescos M; Oppenheimer F
Nephrol Dial Transplant; 2001; 16 Suppl 1():114-6. PubMed ID: 11369837
[TBL] [Abstract][Full Text] [Related]
8. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.
Scaglione R; Argano C; Corrao S; Di Chiara T; Licata A; Licata G
J Hypertens; 2005 Mar; 23(3):657-64. PubMed ID: 15716710
[TBL] [Abstract][Full Text] [Related]
11. [Influence of transforming growth factor beta1 on long-term renal allograft function].
Wang PX; Fan MQ; Huang CB; Zhnag GF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1352-5. PubMed ID: 16982454
[TBL] [Abstract][Full Text] [Related]
12. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney.
Yim HE; Kim MK; Bae IS; Kim JH; Choi BM; Yoo KH; Hong YS; Lee JW
Pediatr Nephrol; 2006 Oct; 21(10):1377-88. PubMed ID: 16897002
[TBL] [Abstract][Full Text] [Related]
13. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy.
Boratyńska M
Ann Transplant; 1999; 4(2):23-8. PubMed ID: 10850587
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cell subtypes and TGF-β1 gene expression in chronic allograft dysfunction.
Assadiasl S; Ahmadpoor P; Nafar M; Lessan Pezeshki M; Pourrezagholi F; Parvin M; Shahlaee A; Sepanjnia A; Nicknam MH; Amirzargar A
Iran J Immunol; 2014 Sep; 11(3):139-52. PubMed ID: 25266000
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
Iñigo P; Campistol JM; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
J Am Soc Nephrol; 2001 Apr; 12(4):822-827. PubMed ID: 11274244
[TBL] [Abstract][Full Text] [Related]
16. The relationship between transforming growth factor beta1 expression and cold ischemia injury of rat donor kidney.
He W; Liu K; Ding H
Exp Mol Pathol; 2010 Feb; 88(1):206-9. PubMed ID: 19874817
[TBL] [Abstract][Full Text] [Related]
17. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
18. [Effect of cytomegalovirus infection on long-term renal allograft function].
Tang B; Lv PY; Xu FY; Zheng KL; Liu D
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1588-91. PubMed ID: 19726300
[TBL] [Abstract][Full Text] [Related]
19. [TGF-beta1 in allograft and long-term renal function].
Wang PX; Huang XY; Wang AJ; Huang CB; Fan MQ; Zhang YP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):700-3. PubMed ID: 16114562
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
